I. I. Giusti

VEGF gene therapy cooperatively recruits molecules from the immune system and stimulates cell homing and angiogenesis in refractory angina

M. Markoski, R. Kalil, N. Nardi, 2017, Cytokine.

Gene therapy for refractory angina and cell therapy for heart failure: experience of a Brazilian research group

M. Markoski, R. Kalil, N. Nardi, 2019, Gene Therapy.

Gene therapy for ischemic heart disease: review of clinical trials.

R. Kalil, N. Nardi, C. Rodrigues, 2011, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.

Terapia gênica para cardiopatia isquêmica: revisão de ensaios clínicos Gene therapy for ischemic heart disease: review of clinical trials

R. Kalil, N. Nardi, C. Rodrigues, 2011 .

isquêmica : revisão de ensaios clínicos Gene therapy for ischemic heart disease : review of clinical trials

R. Kalil, N. Nardi, C. Rodrigues, 2022 .

VEGF gene therapy for angiogenesis in refractory angina: phase I/II clinical trial.

R. Kalil, N. Nardi, C. Rodrigues, 2010, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.

Terapia gênica para cardiopatia isquêmica: review of clinical trials

R. Kalil, N. Nardi, C. Rodrigues, 2011 .

High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease.

M. Markoski, R. Kalil, N. Nardi, 2013, Human gene therapy methods.

VEGF 165 Gene Therapy for Patients with Refractory Angina: Mobilization of Endothelial Progenitor Cells

M. Markoski, R. Kalil, C. Rodrigues, 2013, Arquivos brasileiros de cardiologia.